The Latest Breaking News from FDA

Infant Botulism Symptoms Can Take Weeks to Appear: Here's What Parents Should Watch For

Infant botulism symptoms can take weeks to appear after the last feeding. Here is exactly what to watch for after the Nara Organics formula recall, and when to seek emergency care.

Medical Daily · Jun 25

Listeria Outbreak Linked to Soft Cheese Kills One and Hospitalizes Eight Across the U.S.

A Listeria outbreak linked to Clover Hill Dairy soft cheese has killed one person and hospitalized eight. Here who is most at risk and what to do if you bought this cheese.

Medical Daily · Jun 25

The $70 Billion Shot in the Dark

The global market for drugs like Ozempic, Wegovy, Mounjaro, and Zepbound was worth roughly $70 billion in 2025 and is projected by JP Morgan to exceed $200 billion by 2030.

International Business Times · Jun 25

One Blood Test Could Detect 50 Cancers at Once — the FDA Decision That Could Change Screening Forever

GRAIL's Galleri blood test may detect up to 50 cancers in one vial. The FDA is reviewing a premarket approval application submitted in January 2026. Here's what you need to know.

Medical Daily · Jun 25

Maharashtra FDA bans serving food in newspapers, issues statewide food safety order

Maharashtra FDA has launched 'Safe Food, Healthy Maharashtra' banning food served on newspapers and enforcing strict hygiene. Hotels, restaurants, and delivery platforms must adhere to new standards, including FSSAI licensing, staff training, and proper food handling. Violators face severe penalties, including imprisonment and licence cancellation, as the state aims to…

The Economic Times · Jun 25

FDA Panel Backs Moderna's First mRNA Flu Shot — What It Could Mean for Your Fall Vaccine

FDA advisers unanimously backed Moderna's mRNA flu vaccine mFlusiva on June 18. Here's what the 9-0 vote means for fall 2026 vaccination and who it would cover.

Medical Daily · Jun 25

What Is Retatrutide? The Experimental Weight Loss Drug Millions Cannot Access, But Has Sparked a White House Meltdown Over Trump's Health

A 79-year-old man's access to the experimental drug Retatrutide through the FDA's Expanded Access programme has sparked controversy, with allegations of political insider influence and White House denials.

International Business Times UK · Jun 24

Aminex: A New Direction in Oncology Emerges from Years of Polyamine Research

Families facing aggressive cancers often find themselves navigating therapies that can be physically demanding, particularly when standard treatments are rendered futile.

International Business Times · Jun 24

RFK Jr.’s moves on animal testing spur Capitol Hill action

In his first two years on the job, Health and Human Services Secretary Robert F. Kennedy Jr. has become a polarizing figure on Capitol Hill, largely because of his vaccine skepticism and distrust of the status quo.  But one of his quieter pushes — ending animal testing in medical research —…

Roll Call · Jun 24

Recalled Baby Formula Sold at Target Is Linked to Infant Botulism — What Parents Must Do Now

Nara Organics baby formula sold at Target is linked to a multistate infant botulism outbreak. Three infants were hospitalized. Learn what to do now.

Medical Daily · Jun 24